{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:44:56Z","timestamp":1792089896084,"version":"4.4.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00705-026-06698-y","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:01:32Z","timestamp":1789142492000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunogenicity of a Vero cell-adapted Japanese encephalitis attenuated virus strain SA14-14-2 VC6"],"prefix":"10.1007","volume":"171","author":[{"given":"Xiaohui","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enyue","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongshan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"6698_CR1","doi-asserted-by":"crossref","unstructured":"Halstead SB, Hills SL, Dubischar K (2018) Japanese encephalitis vaccines. In: Plotkin SA, Orenstein WA, Offit PA (eds) Vaccines. Elsevier, pp 511\u2013548","DOI":"10.1016\/B978-0-323-35761-6.00033-X"},{"issue":"6","key":"6698_CR2","first-page":"450","volume":"41","author":"DW Trent","year":"2012","unstructured":"Trent DW, Minor P, Jivapaisarnpong T et al (2012) WHO working group on the quality, safety and efficacy of Japanese encephalitis vaccines (live attenuated) for human use. Bangkok Thail Biol 41(6):450\u2013457","journal-title":"Bangkok Thail Biol"},{"key":"6698_CR3","unstructured":"SAGE Working Group on Japanese Encephalitis Vaccine Background paper on Japanese encephalitis vaccines[M]. Geneva:World Health Organ. 2014: 1\u201317. https:\/\/www.who.int\/immunization\/sage\/meetings\/2014\/october\/1_JE_Vaccine_Background_Paper.pdf"},{"key":"6698_CR4","doi-asserted-by":"publisher","unstructured":"Yu Y (2013) Development of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and its charcteristics [Internet]. Encephalitis. InTech; https:\/\/doi.org\/10.5772\/52980","DOI":"10.5772\/52980"},{"issue":"3","key":"6698_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.16505\/j.2095-0136.2012.03.001","volume":"3","author":"YX Yu","year":"2012","unstructured":"Yu YX (2012) Progress on the development of new Japanese encephalitis vaccines based on SA14-14-2 attenuated virus strain. Chin J Viral Dis 3(3):161\u2013168 (In Chinese). https:\/\/link.cnki.net\/doi\/https:\/\/doi.org\/10.16505\/j.2095-0136.2012.03.001","journal-title":"Chin J Viral Dis"},{"issue":"10","key":"6698_CR6","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.13200\/j.cnki.cjb.003439","volume":"34","author":"YX Yu","year":"2021","unstructured":"Yu YX, Li YH, Jia LL (2021) Application status, safety evaluation and development trend of live attenuated Japanese encephalitis vaccine prepared with SA14-14-2 strain. Chin J Biol 34(10):1145\u20131150 (In Chinese). https:\/\/link.cnki.net\/doi\/https:\/\/doi.org\/10.13200\/j.cnki.cjb.003439","journal-title":"Chin J Biol"},{"key":"6698_CR7","unstructured":"Q-ONE Biotech (2000) Independent GLP testing report on safety of live-attenuated JE vaccine seed and PHK cells"},{"issue":"10","key":"6698_CR8","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1080\/21645515.2017.1356496","volume":"13","author":"AS Insburg","year":"2017","unstructured":"Insburg AS, Meghani A, Halstead SB et al (2017) Use of the live attenuated Japanese encephalitis vaccine SA14-14-2 in children: A review of safety and tolerability studies. Hum Vaccines Immunotherapeutics 13(10):2222\u20132231. https:\/\/doi.org\/10.1080\/21645515.2017.1356496","journal-title":"Hum Vaccines Immunotherapeutics"},{"issue":"27","key":"6698_CR9","doi-asserted-by":"publisher","first-page":"5041","DOI":"10.1016\/j.vaccine.2007.04.052","volume":"25","author":"JB Tandang","year":"2007","unstructured":"Tandang JB, Ohrr H, Sohn YM et al (2007) Single dose of SA14-14-2 vaccine provides long-term protection against Japanese encephalitis: A case-control study in Nepalese children 5 years after immunization. Vaccine 25(27):5041\u20135045. https:\/\/doi.org\/10.1016\/j.vaccine.2007.04.052","journal-title":"Vaccine"},{"issue":"14","key":"6698_CR10","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1056\/NEJMc0808664","volume":"360","author":"R Kumar","year":"2009","unstructured":"Kumar R, Tripathi P, Rizvi A (2009) Effectiveness of one dose of SA 14-14-2 vaccine against Japanese encephalitis.[J]. N Engl J Med 360(14):1465\u20131466. https:\/\/doi.org\/10.1056\/NEJMc0808664","journal-title":"N Engl J Med"},{"issue":"1","key":"6698_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.19914\/j.cjvi.2020.01.001","volume":"26","author":"D Wu","year":"2020","unstructured":"Wu D, Yin ZD, Li JH et al (2020) Epidemiology of Japanese encephalitis in China, 2014\u20132018. Chin J Vaccines Immun 26(1):1\u20134 (In Chinese). https:\/\/link.cnki.net\/doi\/https:\/\/doi.org\/10.19914\/j.cjvi.2020.01.001","journal-title":"Chin J Vaccines Immun"},{"issue":"3","key":"6698_CR12","doi-asserted-by":"publisher","first-page":"464","DOI":"10.4269\/ajtmh.12-0196","volume":"88","author":"SR Upreti","year":"2013","unstructured":"Upreti SR, Janusz KB, Schluter WW et al (2013) Estimation of the impact of a japanese encephalitis immunization program with live, attenuated SA 14-14-2 Vaccine in Nepal[J].The American society of tropical medicine and hygiene. 88(3):464\u2013468. https:\/\/doi.org\/10.4269\/ajtmh.12-0196","journal-title":"The American society of tropical medicine and hygiene."},{"key":"6698_CR13","unstructured":"Anonymous THE FIRSt Chinese vaccine to go global in its entirety (2020 ) Int J Biol 43(4), C1\u2013C2. (In Chinese)"},{"key":"6698_CR14","unstructured":"Guo YS (2013) The first vaccine product of China has passed the WHO pre-qualification and entered the United Nations procurement list. Chin J Med Guide, (10):1552\u20131552. (In Chinese)"},{"issue":"6","key":"6698_CR15","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3760\/cma.j.cn311962-20230306-00022","volume":"46","author":"XH Liu","year":"2023","unstructured":"Liu XH, Li M, Liu XY et al (2023) Selection of Japanese encephalitis virus SA14-14-2 Vero cell live vaccine candidate and study on its phenotypic and genotypic characteristics. Int J Biol 46(6):315\u2013322 (In Chinese). http:\/\/dx.chinadoi.cn\/https:\/\/doi.org\/10.3760\/cma.j.cn311962-20230306-00022","journal-title":"Int J Biol"},{"issue":"4","key":"6698_CR16","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/jnnp.68.4.405","volume":"68","author":"T Solomon","year":"2000","unstructured":"Solomon T, Dung NM, Kneen R et al (2000) Japanese encephalitis. J Neurol Neurosurg Psychiatry 68(4):405\u2013415. https:\/\/doi.org\/10.1136\/jnnp.68.4.405","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"6698_CR17","doi-asserted-by":"publisher","first-page":"e378","DOI":"10.1016\/S1473-3099(17)30362-6","volume":"17","author":"SB Halstead","year":"2017","unstructured":"Halstead SB (2017) Achieving safe, effective, and durable Zika virus vaccines: Lessons from dengue. Lancet Infect Dis 17(11):e378\u2013e382. https:\/\/doi.org\/10.1016\/S1473-3099(17)30362-6","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"6698_CR18","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1586\/14760584.2016.1115727","volume":"15","author":"SS Whitehead","year":"2016","unstructured":"Whitehead SS (2016) Development of TV003\/TV005, a single dose, highly immunogenic live-attenuated dengue vaccine; what makes this vaccine different from the Sanofi-Pasteur CYD\u2122 vaccine? Expert Rev Vaccines 15(4):509\u2013517. https:\/\/doi.org\/10.1586\/14760584.2016.1115727","journal-title":"Expert Rev Vaccines"},{"issue":"2","key":"6698_CR19","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1002\/mco2.117","volume":"3","author":"EY Fang","year":"2022","unstructured":"Fang EY, Liu XH, Liu XY et al (2022) Investigation of immune response induction by Japanese encephalitis live-attenuated and chimeric vaccines in mice. Med Commun 3(2):e117. https:\/\/doi.org\/10.1002\/mco2.117","journal-title":"Med Commun"},{"key":"6698_CR20","doi-asserted-by":"publisher","unstructured":"Turtle L, Tatullo F, Bali T et al (2017) Cellular immune responses to live attenuated Japanese encephalitis (JE) vaccine SA14-14-2 in adults in a JE\/dengue co-endemic area. PLoS Negl Trop Dis 11(1e0005263. https:\/\/doi.org\/10.1371\/journal.pntd.0005263","DOI":"10.1371\/journal.pntd.0005263"},{"issue":"41","key":"6698_CR21","doi-asserted-by":"publisher","first-page":"4501","DOI":"10.1016\/j.vaccine.2013.06.079","volume":"31","author":"SB Halstead","year":"2013","unstructured":"Halstead SB (2013) Identifying protective dengue vaccines: Guide to mastering an empirical process. Vaccine 31(41):4501\u20134507. https:\/\/doi.org\/10.1016\/j.vaccine.2013.06.079","journal-title":"Vaccine"},{"issue":"4","key":"6698_CR22","doi-asserted-by":"publisher","first-page":"741","DOI":"10.4269\/ajtmh.16-0222","volume":"95","author":"SB Halstead","year":"2016","unstructured":"Halstead SB (2016) Licensed dengue vaccine: Public health conundrum and scientific challenge. Am J Trop Med Hyg 95(4):741\u2013745. https:\/\/doi.org\/10.4269\/ajtmh.16-0222","journal-title":"Am J Trop Med Hyg"},{"key":"6698_CR23","doi-asserted-by":"publisher","unstructured":"Halstead SB (2017) Which dengue vaccine approach is the most promising, and should we be concerned about enhanced disease after vaccination: There is one true winner. Cold Spring Harb Perspect Biol, 10(6), a030700. https:\/\/doi.org\/10.1101\/cshperspect.a030700","DOI":"10.1101\/cshperspect.a030700"},{"key":"6698_CR24","doi-asserted-by":"publisher","unstructured":"Grifoni A, Voic H, Dhanda SK et al (2020) T cell responses induced by attenuated flavivirus vaccination are specific and show limited cross-reactivity with other flavivirus species. J Virol, 94(10), e00089\u2013e00020. https:\/\/doi.org\/10.1128\/JVI.00089-20","DOI":"10.1128\/JVI.00089-20"},{"issue":"4","key":"6698_CR25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3390\/vaccines6040073","volume":"6","author":"G Li","year":"2018","unstructured":"Li G, Teleki C, Wang T et al (2018) Memory T cells in flavivirus vaccination. Vaccines 6(4):73. https:\/\/doi.org\/10.3390\/vaccines6040073","journal-title":"Vaccines"},{"issue":"6","key":"6698_CR26","doi-asserted-by":"publisher","first-page":"471","DOI":"10.16505\/j.2095-0136.2016.06.010","volume":"6","author":"N Chen","year":"2016","unstructured":"Chen N, Shi LT, Yu Y (2016) X. Research progress and prospect on dengue vaccine. Chin J Viral Dis 6(6):471\u2013480 (In Chinese). https:\/\/link.cnki.net\/doi\/https:\/\/doi.org\/10.16505\/j.2095-0136.2016.06.010","journal-title":"Chin J Viral Dis"},{"issue":"4","key":"6698_CR27","doi-asserted-by":"publisher","first-page":"330","DOI":"10.19914\/j.cjvi.2010.04.010","volume":"16","author":"MG Li","year":"2010","unstructured":"Li MG, Yu YX, Liu XY et al (2010) Study on persistent cellular immunity of live attenuated SA14-14-2 Japanese encephalitis vaccine in mice. Chin J Vaccines Immun 16(4):330\u2013333 (In Chinese). https:\/\/doi.org\/10.19914\/j.cjvi.2010.04.010https:\/\/link.cnki.net\/doi\/","journal-title":"Chin J Vaccines Immun"},{"issue":"4","key":"6698_CR28","doi-asserted-by":"publisher","first-page":"e285","DOI":"10.1016\/j.ijid.2011.12.010","volume":"16","author":"JS Zhang","year":"2012","unstructured":"Zhang JS, Zhao QM, Zuo SQ et al (2012) Cytokine and chemokine responses to Japanese encephalitis live attenuated vaccine in a human population. Int J Infect Dis 16(4):e285\u2013e288. https:\/\/doi.org\/10.1016\/j.ijid.2011.12.010","journal-title":"Int J Infect Dis"},{"key":"6698_CR29","doi-asserted-by":"publisher","unstructured":"Shen CF, Guilbault C, Li X, Elahi SM , R\u00e9nald Gilbert et al (2019) Development of suspension adapted vero cell culture process technology for production of viral vaccines. Vaccine, : 37(47). https:\/\/doi.org\/10.1016\/j.vaccine.2019.07.003","DOI":"10.1016\/j.vaccine.2019.07.003"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-026-06698-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00705-026-06698-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-026-06698-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:46:21Z","timestamp":1792086381000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00705-026-06698-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["6698"],"URL":"https:\/\/doi.org\/10.1007\/s00705-026-06698-y","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"assertion":[{"value":"13 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were approved by the Experimental Animal Welfare and Ethics Committee of the National Institutes for Food and Drug Control, China (approval code: 2019(A) 062) and conducted in accordance with the Guidelines for the Care and Use of Laboratory Animals.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"276"}}